MIR4763: A Potential Drug Target and Biomarker (G100616143)
MIR4763: A Potential Drug Target and Biomarker
Molecular Intelligence (MOI) has identified a potential drug target and biomarker for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The target is MIR4763, a gene that has been shown to play a crucial role in the development and progression of these diseases. In this article, we will explore the discovery of MIR4763 as a potential drug target and biomarker, as well as its potential therapeutic applications.
The Identification of MIR4763 as a Potential Drug Target
MIR4763 is a gene that encodes a protein known as miR-4763. The protein is composed of 294 amino acid residues and has a molecular weight of 6.4 kDa. MIR4763 is a microRNA (miRNA), which is a small non-coding RNA molecule that plays a crucial role in post-transcriptional gene regulation. miRNAs have been shown to play a key role in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation.
Recent studies have shown that MIR4763 is involved in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation. For example, MIR4763 has been shown to play a role in the regulation of cell cycle progression and the apoptosis of cancer cells. Additionally, MIR4763 has been shown to regulate the production of pro-inflammatory cytokines, which can contribute to the development of neurodegenerative diseases.
The Potential Therapeutic Applications of MIR4763 as a Drug Target
The potential therapeutic applications of MIR4763 as a drug target are vast and varied. One of the most promising applications is the treatment of cancer. MIR4763 has been shown to play a role in the regulation of cell cycle progression and the apoptosis of cancer cells, which suggests that it may have a role in the development and progression of cancer. Therefore, targeting MIR4763 with drugs that can inhibit its activity may be an effective way to treat cancer.
Another potential therapeutic application of MIR4763 is the treatment of neurodegenerative diseases. MIR4763 has been shown to play a role in the regulation of the production of pro-inflammatory cytokines, which can contribute to the development and progression of neurodegenerative diseases. Therefore, targeting MIR4763 with drugs that can inhibit its activity may be an effective way to treat neurodegenerative diseases.
In addition to cancer and neurodegenerative diseases, MIR4763 may also have potential therapeutic applications in other areas, such as autoimmune disorders. MIR4763 has been shown to play a role in the regulation of the production of cytokines that can contribute to the development and progression of autoimmune disorders. Therefore, targeting MIR4763 with drugs that can inhibit its activity may be an effective way to treat autoimmune disorders.
The Identification of MIR4763 as a Potential Biomarker
In addition to its potential therapeutic applications, MIR4763 may also be a useful biomarker for the diagnosis and monitoring of various diseases. The MIR4763 gene has been shown to encode a protein that is involved in the regulation of cellular processes, including cell growth, apoptosis, and inflammation. Therefore, measuring the levels of MIR4763 in cells or fluids, such as blood or urine, may be a useful biomarker for the diagnosis and monitoring of various diseases.
One of the potential applications of MIR4763 as a biomarker is the detection of cancer. MIR4763 has
Protein Name: MicroRNA 4763
The "MIR4763 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4763 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4764 | MIR4765 | MIR4766 | MIR4767 | MIR4768 | MIR4769 | MIR4770 | MIR4771-1 | MIR4771-2 | MIR4772 | MIR4773-1 | MIR4773-2 | MIR4774 | MIR4775 | MIR4776-1 | MIR4776-2 | MIR4777 | MIR4778 | MIR4779 | MIR4780 | MIR4781 | MIR4782 | MIR4783 | MIR4784 | MIR4785 | MIR4786 | MIR4787 | MIR4789 | MIR4790 | MIR4791 | MIR4793 | MIR4794 | MIR4795 | MIR4796 | MIR4797 | MIR4798 | MIR4799 | MIR4800 | MIR4802 | MIR4803 | MIR4804 | MIR483 | MIR484 | MIR485 | MIR486-1 | MIR486-2 | MIR487A | MIR487B | MIR488 | MIR489 | MIR490 | MIR491 | MIR492 | MIR493 | MIR494 | MIR495 | MIR496 | MIR497 | MIR497HG | MIR498 | MIR4999 | MIR499A | MIR499B | MIR5000 | MIR5001 | MIR5002 | MIR5003 | MIR5004 | MIR5006 | MIR5007 | MIR5008 | MIR5009 | MIR500A | MIR500B | MIR501 | MIR5010 | MIR5011 | MIR502 | MIR503 | MIR503HG | MIR504 | MIR5047 | MIR505 | MIR506 | MIR507 | MIR508 | MIR5088 | MIR5089 | MIR509-1 | MIR509-2 | MIR509-3 | MIR5090 | MIR5091 | MIR5092 | MIR5093 | MIR5094 | MIR510 | MIR5100 | MIR511 | MIR511-2
